By Product
Currency:CNY
2025/H1
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2019/H1
2018/FY
2018/H1
2017/FY
2017/H1
2016/FY
2016/H1
2015/FY
2015/H1
2014/FY
2014/H1
2013/FY
2013/H1
2012/FY
2012/H1
2011/FY
2010/FY
2009/FY
2008/FY
Stock NameRevenueRatio
Low molecular weight heparin preparation204.49M41.60%
Total special adjustments181.28M36.87%
Common heparin drug94.01M19.12%
Other business11.83M2.41%
By Industry
Currency:CNY
2025/H1
2025/H1
2024/FY
2024/H1
2023/FY
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2019/H1
2018/FY
2018/H1
2017/FY
2017/H1
2016/FY
2016/H1
2015/FY
2015/H1
2014/FY
2014/H1
2013/FY
2013/H1
2012/FY
2012/H1
2011/FY
Stock NameRevenueRatio
Water needle preparation233.38M47.47%
肝素原料药192.92M39.24%
Other65.31M13.29%
By Country/Region
Currency:CNY
2025/H1
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2019/H1
2018/FY
2018/H1
2017/FY
2017/H1
2016/FY
2016/H1
2015/FY
2015/H1
2014/FY
2014/H1
2013/FY
2013/H1
2012/FY
2012/H1
2011/FY
2010/FY
2009/FY
2008/FY
Stock NameRevenueRatio
Domestic387.37M78.80%
Abroad104.24M21.20%